News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cardiex.
RELATED STOCKHEAD STORIES
Health & Biotech
CardieX pumped up with insto support for $4.33 million raise – announces additional purchase plan for shareholders
News
ASX Quarterlies: Companies shine amidst market volatility
Health & Biotech
ASX Health Stocks: Orthocell up 35pc after shaking on exclusive global patent deal
Health & Biotech
CardieX ratchets up commercialisation strategy with FDA lodgement for CONNEQT Pulse
News
Weekly Small Cap and IPO Wrap: In a pickle? Just buy Nordic Nickel
News
Closing Bell: Thank heavens for the earth, as miners and metals keep everything afloat
Health & Biotech
CardieX gets hearts racing as MST Access reaffirms value at 5x current share price
Health & Biotech
ASX Health Stocks: Imugene begins Phase 1 trial of its cancer-fighting virus
News
ASX Small Cap Lunch Wrap: Who’s competing for the ultimate title today?
Health & Biotech
ASX Health Stocks: Opthea presents data at global conference; CardieX to progress Philip Morris sponsored study
Stockhead TV
Health Tech: New innovations geared toward personalised care post pandemic
Health & Biotech
Oh, it’s a buy: analyst upgrade places CardieX at triple current share price
Health & Biotech
ASX medtech CardieX accelerates go-to-market strategy following strong Options take up
Health & Biotech
ASX Health Stocks: Sigma downgrades earnings, and chairman’s death at Asian American Medical
Health & Biotech
CardieX cranks up commercialisation strategy with imminent launch of wearable heart health device with Mobvoi
Tech
Apple wants to make its new watch a one-stop heart-monitoring shop; but this ASX stock might get there first
Stockhead TV